Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78
収録刊行物
-
- Frontiers in Oncology
-
Frontiers in Oncology 9 1530-, 2020-01-22
Frontiers Media SA